Morphine vs Sufentanil PCA: Same Same or Different?
Status:
Completed
Trial end date:
2020-10-31
Target enrollment:
Participant gender:
Summary
Patient-controlled intravenous analgesia (PCA) has already proven its quality. However, with
new strategies starting to emerge and the current concept of opioid sparing, it is a goal to
find the optimal PCA strategy capable of improve patient satisfaction and, at the same time,
individualize opioid dose.
In a prospected randomized study, it was compared the use of Sufentanil Sublingual PCA System
with intravenous PCA Morphine in terms of postoperative pain control satisfaction, total dose
of opioid required, adverse effects, impact on the quality of postoperative recovery and the
incidence of postoperative chronic pain.